Mike Sathekge is an expert in Nuclear medicine at Steve Biko Hospital (South Africa). As of October 2026, ScienceLeadR ranks Mike Sathekge in the top 1% of experts in South Africa for Prostatic Diseases, Urogenital Neoplasms and Genital Diseases, Male. Mike Sathekge has authored 370 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,264 (community average: 125). How the SLR is computed.

LeadR Profile

Mike Sathekge Steve Biko Hospital South Africa
1 264 ScienceLeadR Reputation 1264
Network Map

Nuclear medicine

Subspecialties: Oncology - Medical Imaging - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1995 - 2026

Source: PubMed

University of Pretoria

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 370

Citations

Citations: 7 092 1st author: 49 Last author: 165 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Small-scale theranostic radiopharmaceutical production using cold kits: a green chemistry perspective.
PMID 42697103 — cold temperature, radiopharmaceuticals, radiobiology, nuclear medicine
Nucl Med Biol20260
Evaluation of the biodistribution of [ 99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [ 68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.
PMID 42613488 — salivary glands, single photon emission computed tomography computed tomography, neoplasms, prostate, positron emission tomography computed tomography, liver, tomography, emission-computed, single-photon, prostatic neoplasms, therapeutics, wounds and injuries
EJNMMI Res20260
Circulating tumour DNA in mCRPC: bridging tumour biology and real-time treatment monitoring.
PMID 42602251 — neoplasms, prostate, biomarkers, therapeutics, liquid biopsy
Front Mol Med20260
Radiation dose optimization and dosimetry in pediatric nuclear medicine: Current concepts and future directions.
PMID 42557153 — safety, single photon emission computed tomography computed tomography, nuclear medicine, therapeutics, child
Semin Nucl Med20262
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.
PMID 42399196 — urology, neoplasms, prostate, prostatic neoplasms, diagnosis
Eur Urol20261

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Completed 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map